Senkron ve metakron akciğer kanserlerinde cerrahi tedavi sonuçları

Cilt: 48 Sayı: 2 1 Haziran 2009
  • Turhan K
  • Yoldaş B
  • Çağırıcı U
  • Çakan A
PDF İndir
EN TR

Outcomes of surgical treatment for synchronous and metachronous lung cancer

Abstract

Aim: At the present day, there is enough knowledge about the effectiveness and patient selection criterias of the surgical therapy for lung cancer. However, there are different opinions and inadequate data about the type of treatment and surgical results of synchronous tumors; defined as two primary tumors with different cell types at the same time and metachronous tumors; which is the second primary tumor that had been seen two years after curative surgical treatment of the first primary tumor. Material and Methods: In this report we reviewed the surgical results of 4 patients with primary lung cancer between January 1997-December 2006, retrospectively. 2 of these patients had synchronous and the other 2 had metachronous lung cancer. Results: All of the patients were male and had a mean age of 60 ± 8.1 (48-65) years. We performed 3 lobectomies and one wedge resection. Mean follow up time was 28.2 ± 15.1 (12-43) months. There was no recurrence during follow up period. Conclusion: Results of survival and disease free survival for synchronous and metachronous lung cancer gained by surgical treatment in our series were satisfactory and this result was consistent to the literature. However, for a certain determination further investigations are required.

Keywords

Ayrıntılar

Birincil Dil

Türkçe

Konular

-

Bölüm

-

Yazarlar

Turhan K

Yoldaş B

Çağırıcı U

Çakan A

Yayımlanma Tarihi

1 Haziran 2009

Gönderilme Tarihi

1 Haziran 2009

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 1970 Cilt: 48 Sayı: 2

Kaynak Göster

Vancouver
1.Turhan K, Yoldaş B, Çağırıcı U, Çakan A. Senkron ve metakron akciğer kanserlerinde cerrahi tedavi sonuçları. ETD [Internet]. 01 Haziran 2009;48(2):85-8. Erişim adresi: https://izlik.org/JA34FD93RN

Ege Tıp Dergisi, makalelerin Atıf-Gayri Ticari-Aynı Lisansla Paylaş 4.0 Uluslararası (CC BY-NC-SA 4.0) lisansına uygun bir şekilde paylaşılmasına izin verir.